The Board of Directors believes the offer doesn’t reflect the firm's long-term potential.
Swedencare’s Board of Directors has unanimously advised against accepting the SEK5.9 billion (€508.6M/$543.77M) offer made by Symrise in June after the German firm reached a 30% stake in the company.
“The Board of Directors, therefore, recommends the shareholders of Swedencare not to accept the Offer,” reads a statement.
Swedencare notes that it sees Symrise as a “strategically important” owner of the company and highlights: “Symrise does not have the ambition to acquire all shares in Swedencare and that the Offer is prompted by legal requirements.”
The regulation establishes that a mandatory offer to the stakeholders must be made when this amount of ownership is reached. Symrise clarified earlier in the month that it intended to increase its shareholding in Swedencare but not to acquire full ownership.
The company targets sales worth SEK4 billion (€338.6M/$367M) by 2026.
The latest articles
CULT Food starts cultivated pet food regulatory race in the US
A subsidiary of the Canadian cell-based firm is to file a feeding trial to seek approval to sell the product in the country.
Purina witnessing a deceleration, admits Nestlé’s CFO
The multinational’s pet portfolio increased sales in the first half of 2024. GlobalPETS dives into the latest earnings.
American biotech companies receive $36 million in investments
California-based NovoNutrients and Digestiva to scale their footprints in alternative protein.
Weekly newsletter to stay up-to-date
Discover what’s happening in the pet industry. Get the must-read stories and insights in your inbox.